Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis

被引:41
作者
Bryan, WW
Reisch, JS
McDonald, G
Herbelin, LL
Barohn, RJ
Fleckenstein, JL
机构
[1] Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Dept Acad Comp Serv, Dallas, TX 75235 USA
[3] Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75235 USA
关键词
D O I
10.1212/WNL.51.1.110
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To characterize leg muscle abnormalities in patients with ALS using MRI, and to correlate MRI with standard neurologic measures of motor neuron dysfunction. Methods: Eleven ALS patients were studied twice (once at baseline and again after 4 months) and compared with eight normal control subjects. MRI data of the lower extremities were compared with tibialis anterior compound muscle action potential amplitude (CMAPa) and foot dorsiflexion maximal voluntary isometric contraction (MVIC). Results: Muscle MRI was abnormal by visual inspection in six of 11 patients. The mean muscle T1 time and muscle volume were not different in patients compared with normal control subjects (p > 0.1). However, the mean T2 times were increased in the patients compared with normal control subjects (p = 0.009). T1 times did not correlate with CMAPa or MVIC. Muscle volume correlated with MVIC (r = 0.73 to 0.78, p < 0.02) but not with CMAPa (p > 0.05). There was a strong negative correlation (r < -0.8, p less than or equal to 0.01) between muscle T2 time and MVIC and CMAPa. Also, the change in T2 relaxation time correlated with the change in CMAPa as the disease progressed (r = -0.63, p = 0.037). Conclusion: Of the MRI characteristics studied, T2 relaxation time was the best indicator of motor neuron dysfunction and may have a role in objective evaluation of motor neuron dysfunction.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 18 条
[1]   QUANTITATIVE MOTOR-ASSESSMENT IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ANDRES, PL ;
HEDLUND, W ;
FINISON, L ;
CONLON, T ;
FELMUS, M ;
MUNSAT, TL .
NEUROLOGY, 1986, 36 (07) :937-941
[2]  
Brooks BR, 1996, NEUROLOGY, V47, pS71, DOI 10.1212/WNL.47.4_Suppl_2.71S
[3]   DENERVATED HUMAN SKELETAL-MUSCLE - MR IMAGING EVALUATION [J].
FLECKENSTEIN, JL ;
WATUMULL, D ;
CONNER, KE ;
EZAKI, M ;
GREENLEE, RG ;
BRYAN, WW ;
CHASON, DP ;
PARKEY, RW ;
PESHOCK, RM ;
PURDY, PD .
RADIOLOGY, 1993, 187 (01) :213-218
[4]  
FLECKENSTEIN JL, 1996, P INT SOC MAGN RESON, V1, P420
[5]  
Hoagland RJ, 1997, MUSCLE NERVE, V20, P691, DOI 10.1002/(SICI)1097-4598(199706)20:6<691::AID-MUS5>3.0.CO
[6]  
2-3
[7]   USE OF ELECTROPHYSIOLOGIC TESTS TO MEASURE DISEASE PROGRESSION IN ALS THERAPEUTIC TRIALS [J].
KELLY, JJ ;
THIBODEAU, L ;
ANDRES, PL ;
FINISON, LJ .
MUSCLE & NERVE, 1990, 13 (06) :471-479
[8]  
Lotz B, 1996, NEUROLOGY, V46, P1244
[9]   Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis [J].
Miller, RG ;
Moore, D ;
Young, LA ;
Armon, C ;
Barohn, RJ ;
Bromberg, MB ;
Bryan, WW ;
Gelinas, DF ;
Mendoza, MC ;
Neville, HE ;
Parry, GJ ;
Petajan, JH ;
Ravits, JM ;
Ringel, SP ;
Ross, MA ;
Quien, A ;
Murphy, J ;
Brinkman, J ;
Burns, D ;
Parsons, J ;
Braiman, J ;
Kelkar, P ;
Hartsock, L ;
Heffner, M ;
Moses, D ;
Riddle, K ;
Furtado, M ;
Doyle, J ;
Graves, J ;
Aulenbacher, D ;
Herbelin, L ;
Ivy, N ;
Forshew, D ;
Mason, V ;
Trafton, L ;
Barbee, M ;
Garofalo, E ;
Hayes, L ;
Leiderman, D ;
Pierce, M .
NEUROLOGY, 1996, 47 (06) :1383-1388
[10]   Controlled trial of nimodipine in amyotrophic lateral sclerosis [J].
Miller, RG ;
Shepherd, R ;
Dao, H ;
Khramstov, A ;
Mendoza, M ;
Graves, J ;
Smith, S .
NEUROMUSCULAR DISORDERS, 1996, 6 (02) :101-104